ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Global Advancements in Prostate Cancer: Best Practices in Hormonal Therapy"
Episode Synopsis
CME Available: https://auau.auanet.org/node/35401
Learning Objectives:
After participating in this educational series, participants will be able to:
1. List advanced prostate cancer disease states (mHSPC); M0 CRPC and M1 CRPC) and be able to identify these patients in urologic practice.
2. Identify available approved therapies and outcomes for each of these disease states: MHSPC, M0 CRPC, M1 CRPC.
3. Demonstrate the appropriate indications, unique mechanisms of action and side effects of new and existing androgen axis agents, immunotherapies, chemotherapeutic agents and bone targeted therapies.
4. Explain the sequencing of available therapies, as well as identifying adverse events that might occur when considering combination therapy.
5. Review the evidence and outcomes on androgen deprivation treatment alone and in combination as outlined in the newly released Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline.
Acknowledgements:
Support provided by independent educational grants from:
AstraZeneca
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck
Learning Objectives:
After participating in this educational series, participants will be able to:
1. List advanced prostate cancer disease states (mHSPC); M0 CRPC and M1 CRPC) and be able to identify these patients in urologic practice.
2. Identify available approved therapies and outcomes for each of these disease states: MHSPC, M0 CRPC, M1 CRPC.
3. Demonstrate the appropriate indications, unique mechanisms of action and side effects of new and existing androgen axis agents, immunotherapies, chemotherapeutic agents and bone targeted therapies.
4. Explain the sequencing of available therapies, as well as identifying adverse events that might occur when considering combination therapy.
5. Review the evidence and outcomes on androgen deprivation treatment alone and in combination as outlined in the newly released Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline.
Acknowledgements:
Support provided by independent educational grants from:
AstraZeneca
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck
More episodes of the podcast AUAUniversity
Core Curriculum: Anorectal Malformation
22/10/2025
The Latest Breakthroughs in mHSPC
24/09/2025
In God we trust